Using Literature-Based Discovery to Explain Adverse Drug Effects

We report on our research in using literature-based discovery (LBD) to provide pharmacological and/or pharmacogenomic explanations for reported adverse drug effects. The goal of LBD is to generate novel and potentially useful hypotheses by analyzing the scientific literature and optionally some additional resources. Our assumption is that drugs have effects on some genes or proteins and that these genes or proteins are associated with the observed adverse effects. Therefore, by using LBD we try to find genes or proteins that link the drugs with the reported adverse effects. These genes or proteins can be used to provide insight into the processes causing the adverse effects. Initial results show that our method has the potential to assist in explaining reported adverse drug effects.

[1]  M. Büchler,et al.  Lipid Peroxidation and Glutathione Metabolism in Chronic Pancreatitis , 1995, Pancreas.

[2]  M Cikrt,et al.  The dependence of biliary methylmercury secretion on liver GSH and ligandin. , 1985, Biochemical pharmacology.

[3]  Andrea Belluzzi,et al.  Asymptomatic and Persistent Elevation of Pancreatic Enzymes in an Ulcerative Colitis Patient , 2013, Case reports in gastrointestinal medicine.

[4]  Taha A. Kass-Hout,et al.  Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter , 2014, Drug Safety.

[5]  Jun-Shik Choi,et al.  Effects of HMG-CoA Reductase Inhibitors on the Pharmacokinetics of Losartan and Its Main Metabolite EXP-3174 in Rats: Possible Role of CYP3A4 and P-gp Inhibition by HMG-CoA Reductase Inhibitors , 2011, Pharmacology.

[6]  Hagit Shatkay,et al.  Linking Literature, Information, and Knowledge for Biology - Workshop of the BioLink Special Interest Group, ISMB/ECCB 2009, Stockholm, Sweden, June 28-29, 2009, Revised Selected Papers , 2010, BioLINK@ISMB/ECCB.

[7]  M. Niemi.  Transporter Pharmacogenetics and Statin Toxicity , 2010, Clinical pharmacology and therapeutics.

[8]  C. Friedman,et al.  A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions , 2015, Drug Safety.

[9]  S Zierz,et al.  [Abnormal regulation of carnitine palmitoyltransferase in monozygotic twins as the cause of rhabdomyolysis]. , 1990, Deutsche medizinische Wochenschrift.

[10]  I. Bilbao,et al.  Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient. , 2009, Transplantation proceedings.

[11]  Marius Fieschi,et al.  Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project , 2013, J. Am. Medical Informatics Assoc..

[12]  P Schmitz-Moormann,et al.  Comparative radiological and morphological study of the human pancreas. IV. Acute necrotizing pancreatitis in man. , 1981, Pathology, research and practice.

[13]  Marcelo Fiszman,et al.  The interaction of domain knowledge and linguistic structure in natural language processing: interpreting hypernymic propositions in biomedical text , 2003, J. Biomed. Informatics.

[14]  L. Gullo,et al.  Serum Pancreatic Enzyme Behavior During the Course of Acute Pancreatitis , 1987, Pancreas.

[15]  Jane K. Stock,et al.  Statin-associated muscle symptoms EAS Consensus Panel paper focuses on this neglected patient group. , 2015, Atherosclerosis.

[16]  K. Tsuneyama,et al.  Knock Down of γ-Glutamylcysteine Synthetase in Rat Causes Acetaminophen-induced Hepatotoxicity* , 2007, Journal of Biological Chemistry.

[17]  J. Kuhn,et al.  Pharmacology of irinotecan. , 1998, Oncology.

[18]  Pernille Warrer,et al.  Using text-mining techniques in electronic patient records to identify ADRs from medicine use. , 2012, British Journal of Clinical Pharmacology.

[19]  Ze-yuan Liu,et al.  Severe irinotecan-induced toxicity in a patient with UGT1A1 28 and UGT1A1 6 polymorphisms. , 2013, World journal of gastroenterology.

[20]  Dejan Dinevski,et al.  Biomedical question answering using semantic relations , 2015, BMC Bioinformatics.

[21]  D. Swanson.  Fish Oil, Raynaud's Syndrome, and Undiscovered Public Knowledge , 2015, Perspectives in biology and medicine.

[22]  Borut Peterlin,et al.  Using literature-based discovery to identify novel therapeutic approaches. , 2013, Cardiovascular & hematological agents in medicinal chemistry.

[23]  J P Keverline.  Recurrent rhabdomyolysis associated with influenza-like illness in a weight-lifter. , 1998, The Journal of sports medicine and physical fitness.

[24]  N. Roglans,et al.  Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats. , 2002, The Journal of pharmacology and experimental therapeutics.

[25]  Keverline Jp.  Recurrent rhabdomyolysis associated with influenza-like illness in a weight-lifter. , 1998 .

[26]  Borut Peterlin,et al.  Combining Semantic Relations and DNA Microarray Data for Novel Hypotheses Generation , 2009, BioLINK@ISMB/ECCB.

[27]  Lyle H. Ungar,et al.  Identifying potential adverse effects using the web: A new approach to medical hypothesis generation , 2011, J. Biomed. Informatics.